Gastric carcinogenesis

被引:37
作者
Bornschein, Jan [1 ]
Malfertheiner, Peter [1 ]
机构
[1] Otto VonGuericke Univ Magdegurg, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany
关键词
Gastric cancer; Helicobacter pylori; Intestinal metaplasia; CagA; Interleukin-1; beta; HELICOBACTER-PYLORI ERADICATION; REGULATORY T-CELLS; CHRONIC ATROPHIC GASTRITIS; E-CADHERIN GENE; INTESTINAL METAPLASIA; CANCER RISK; FOLLOW-UP; CYCLOOXYGENASE-2; EXPRESSION; INTERLEUKIN-1; POLYMORPHISMS; EPITHELIAL-CELLS;
D O I
10.1007/s00423-011-0810-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction In most patients, gastric cancer is diagnosed in advanced stage. Curative treatment options are limited and the mortality is high. The process of gastric carcinogenesis is triggered by Helicobacter pylori-driven gastritis and is further characterized by its complexity of interaction with other risk factors. Health care systems are challenged for the improvement of prevention, early diagnosis, and effective treatments. Methods An extensive literature research has been performed to elucidate the interplay between etiological factors involved in gastric carcinogenesis. Results H. pylori is the most important carcinogen for gastric adenocarcinoma. Evidence is provided by experiments including animal studies as well as clinical observational and interventional studies in humans. Eradication has the potential to prevent gastric cancer and offers the greatest benefit if performed before premalignant changes of the gastric mucosa have occurred. Bacterial virulence factors are essential players in modulating the immune response involved in the initiation of the carcinogenesis in the stomach. Host genetic factors contribute to the regulation of the inflammatory response and in the aggravation of mucosal damage. The harmful role of environmental factors is restricted to salt intake and smoking of tobacco. The ingestion of fruit and vegetables has some protective effect. Conclusion Infection with H. pylori is the major risk factor for gastric cancer development, and thus, eradication of the Helicobacter offers a promising best option for prevention of the disease. Bacterial virulence, host genetic factors, and environmental influences are interacting in the multifactorial process of gastric carcinogenesis.
引用
收藏
页码:729 / 742
页数:14
相关论文
共 168 条
[21]   Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1β cytokine in Korean patients with gastric cancer [J].
Chang, YW ;
Jang, JY ;
Kim, NH ;
Lee, JW ;
Lee, HJ ;
Jung, WW ;
Dong, SH ;
Kim, HJ ;
Kim, BH ;
Lee, JI ;
Chang, R .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (03) :465-471
[22]   EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century [J].
Coleman, M. P. ;
Gatta, G. ;
Verdecchia, A. ;
Esteve, J. ;
Sant, M. ;
Storm, H. ;
Allemani, C. ;
Ciccolallo, L. ;
Santaquilani, M. ;
Berrino, F. .
ANNALS OF ONCOLOGY, 2003, 14 :V128-V149
[23]   Chemoprevention of gastric dysplasia:: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy [J].
Correa, P ;
Fontham, ETH ;
Bravo, JC ;
Bravo, LE ;
Ruiz, B ;
Zarama, G ;
Realpe, JL ;
Malcom, GT ;
Li, D ;
Johnson, WD ;
Mera, R .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (23) :1881-1888
[24]   Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST) [J].
Crusius, J. B. A. ;
Canzian, F. ;
Capella, G. ;
Pena, A. S. ;
Pera, G. ;
Sala, N. ;
Agudo, A. ;
Rico, F. ;
Del Giudice, G. ;
Palli, D. ;
Plebani, M. ;
Boeing, H. ;
Bueno-de-Mesquita, H. B. ;
Carneiro, F. ;
Pala, V. ;
Save, V. E. ;
Vineis, P. ;
Tumino, R. ;
Panico, S. ;
Berglund, G. ;
Manjer, J. ;
Stenling, R. ;
Hallmans, G. ;
Martinez, C. ;
Dorronsoro, M. ;
Barricarte, A. ;
Navarro, C. ;
Quiros, J. R. ;
Allen, N. ;
Key, T. J. ;
Binghan, S. ;
Caldas, C. ;
Linseisen, J. ;
Kaaks, R. ;
Overvad, K. ;
Tjonneland, A. ;
Buechner, F. C. ;
Peeters, P. H. M. ;
Numans, M. E. ;
Clavel-Chapelon, F. ;
Trichopoulou, A. ;
Lund, E. ;
Jenab, M. ;
Rinaldi, S. ;
Ferrari, P. ;
Riboli, E. ;
Gonzalez, C. A. .
ANNALS OF ONCOLOGY, 2008, 19 (11) :1894-1902
[25]   Endoscopic screening for gastric cancer [J].
Dan, Yock Young ;
So, J. B. Y. ;
Yeoh, Khay Guan .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (06) :709-716
[26]   Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn? [J].
de Vries, A. C. ;
Kuipers, E. J. ;
Rauws, E. A. J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (06) :1342-1345
[27]   Gastric cancer risk in patients with premalignant gastric lesions: A nationwide cohort study in the Netherlands [J].
de Vries, Annemarie C. ;
van Grieken, Nicole C. T. ;
Looman, Caspar W. N. ;
Casparie, Mariel K. ;
de Vries, Esther ;
Meijer, Gerrit A. ;
Kuipers, Ernst J. .
GASTROENTEROLOGY, 2008, 134 (04) :945-952
[28]   Development of vaccines against Helicobacter pylori [J].
Del Giudice, Giuseppe ;
Malfertheiner, Peter ;
Rappuoli, Rino .
EXPERT REVIEW OF VACCINES, 2009, 8 (08) :1037-1049
[29]  
Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005
[30]   Reversal of gastric atrophy after Helicobacter pylori eradication:: Is it possible or not? [J].
Domellöf, L .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (09) :1407-1408